Law360, New York (July 07, 2005, 12:00 AM ET) -- Brazil’s government and Abbott Laboratories are in last-minute talks to avoid a compulsory license on the U.S. drug maker’s AIDS therapy Kaletra, the company said.
Brazil's ministry of health had given Abbott until midnight on Thursday to reduce its prices, but there was no word Friday morning on whether the two partied had been able to come to an agreement.
Abbott presented a new proposal shortly before the government's midnight deadline for agreement, and health ministry officials were said to be studying the company's final offer....
Abbott Races To Beat Clock In Patent Brawl With Brazil
To view the full article, take a free trial now.
